Actual results depend on dose, adherence, metabolic factors, and lifestyle
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association
Its plasma half-life was longer than GLP-1, reaching 100~120 min
Wegovy vs
Mounjaro (tirzepatide) tends to produce greater weight loss in clinical studies and targets two receptors versus one
And then if they start to feel less energy, or perhaps theyre losing some muscle mass, theyre going to start to seek out different types of foods and different types of nutrients
